Integrated Filing — IndAS

General information about company
Scrip Code	540153
NSE Symbol	ENDURANCE
MSEI Symbol	NOTLISTED
ISIN	INE913H01037
Name of company	Endurance Technologies Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	15-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	25-Mar-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Auto Components
Start date and time of board meeting	15-May-2025   12:45:00
End date and time of board meeting	15-May-2025   18:50:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	No
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-02-12
Indicate Company website link for updated RPT policy of the Company	https://www.endurancegroup.com/investor-relations/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	22489930000	88461480000
	Other income	203870000	665820000
	Total income	22693800000	89127300000
2	Expenses
(a)	Cost of materials consumed	13729950000	56863470000
(b)	Purchases of stock-in-trade	199100000	706730000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	530920000	-285690000
(d)	Employee benefit expense	1113480000	4357760000
(e)	Finance costs	6780000	25620000
(f)	Depreciation, depletion and amortisation expense	742450000	2896510000
(f)	Other Expenses
1	Other Expenses	3861820000	15308690000
	Total other expenses	3861820000	15308690000
	Total expenses	20184500000	79873090000
3	Total profit before exceptional items and tax	2509300000	9254210000
4	Exceptional items	-173590000	-173590000
5	Total profit before tax	2335710000	9080620000
6	Tax expense
7	Current tax	579730000	2275220000
8	Deferred tax	15140000	18810000
9	Total tax expenses	594870000	2294030000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	1740840000	6786590000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	1740840000	6786590000
17	Other comprehensive income net of taxes	-29050000	-164070000
18	Total Comprehensive Income for the period	1711790000	6622520000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	1406630000	1406630000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		42073460000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	12.38	48.25
	Diluted earnings (loss) per share from continuing operations	12.38	48.25
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	12.38	48.25
	Diluted earnings (loss) per share from continuing and discontinued operations	12.38	48.25
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	19644570000
	Capital work-in-progress	2069670000
	Investment property	0
	Goodwill	0
	Other intangible assets	608520000
	Intangible assets under development	28150000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	5219710000
	Trade receivables, non-current	0
	Loans, non-current	137000000
	Other non-current financial assets	135820000
	Total non-current financial assets	5492530000
	Deferred tax assets (net)	0
	Other non-current assets	624740000
	Total non-current assets	28468180000
2	Current assets
	Inventories	5620830000
	Current financial asset
	Current investments	5183650000
	Trade receivables, current	11322490000
	Cash and cash equivalents	921480000
	Bank balance other than cash and cash equivalents	450000
	Loans, current	33630000
	Other current financial assets	1944850000
	Total current financial assets	19406550000
	Current tax assets (net)	0
	Other current assets	463430000
	Total current assets	25490810000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	53958990000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	1406630000
	Other equity	42073460000
	Total equity attributable to owners of parent	43480090000
	Non controlling interest
	Total equity	43480090000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	194420000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	133270000
	Total non-current financial liabilities	327690000
	Provisions, non-current	35950000
	Deferred tax liabilities (net)	133540000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	497180000
	Current liabilities
	Current financial liabilities
	Borrowings, current	51870000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	1012740000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	7137380000
	Total Trade payable	8150120000
	Other current financial liabilities	599760000
	Total current financial liabilities	8801750000
	Other current liabilities	759470000
	Provisions, current	260120000
	Current tax liabilities (Net)	160380000
	Deferred government grants, Current	0
	Total current liabilities	9981720000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	10478900000
	Total equity and liabilites	53958990000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurements of defined benefit plans	-2940000	-43770000
2	Gain/(loss) on change in fair value of equity instruments	-8160000	-143620000
	Total Amount of items that will not be reclassified to profit and loss	-11100000	-187390000
2	Income tax relating to items that will not be reclassified to profit or loss	17950000	-23320000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-29050000	-164070000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			9080620000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			0
	Adjustments for decrease (increase) in inventories			-803690000
	Adjustments for decrease (increase) in trade receivables, current			-710760000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-259000000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			-319780000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			1308110000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			2960000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			2896510000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			-29780000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			4300000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-14960000
	Adjustments for dividend income			0
	Adjustments for interest income			0
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-463530000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			155240000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			1765620000
	Net cash flows from (used in) operations			10846240000
	Dividends received			-2560000
	Interest paid			-19750000
	Interest received			-22040000
	Income taxes paid (refund)			2106550000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			8734840000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			10000
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			827910000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			225980000
	Purchase of property, plant and equipment			6110850000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			37000000
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			2560000
	Interest received			18990000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			90000
	Net cash flows from (used in) investing activities	-6728150000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			0
	Payments of lease liabilities			33800000
	Dividends paid			1195610000
	Interest paid			12680000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-1242090000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			764600000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			764600000
	Cash and cash equivalents cash flow statement at beginning of period			156880000
	Cash and cash equivalents cash flow statement at end of period			921480000